AS
CORT icon

Altshuler Shaham’s Corcept Therapeutics CORT Stock Holding History

Altshuler Shaham’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.7K Hold
100
– – ﹤0.01% 331
2026
Q1 		$4.03K Sell
100
-100
-50% -$3.74K ﹤0.01% 320
2025
Q4 		$6.96K Buy
200
+141
+239% +$11.1K ﹤0.01% 267
2025
Q3 		$4.9K Hold
59
– – ﹤0.01% 250
2025
Q2 		$4.33K Sell
59
-10
-14% -$725 ﹤0.01% 245
2025
Q1 		$7.88K Buy
+69
New +$4.2K ﹤0.01% 201
2023
Q4 		– Sell
-728
Closed -$19.8K – 273
2023
Q3 		$19.8K Buy
+728
New +$21.1K ﹤0.01% 254
2023
Q1 		– Sell
-2,580
Closed -$52.4K – 396
2022
Q4 		$52.4K Buy
2,580
+294
+13% +$7.37K ﹤0.01% 207
2022
Q3 		$58K Buy
2,286
+922
+68% +$24.7K ﹤0.01% 195
2022
Q2 		$32K Sell
1,364
-226
-14% -$4.92K ﹤0.01% 308
2022
Q1 		$36K Buy
+1,590
New +$33.8K ﹤0.01% 455
2020
Q3 		– Sell
-1,352
Closed -$23K – 389
2020
Q2 		$23K Buy
+1,352
New +$19K ﹤0.01% 248

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Altshuler Shaham's CORT Position: Q2 2026 in Review

Altshuler Shaham held its Corcept Therapeutics (CORT) position steady in Q2 2026 at 100 shares worth $8.7K. The position accounts for ﹤0.01% of the portfolio, ranked #331.

Altshuler Shaham first reported a position in CORT in Q2 2020 and has held it in 12 quarters since. The position peaked at $58K in Q3 2022. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Altshuler Shaham held 100 shares of Corcept Therapeutics worth $8.7K as of Q2 2026.
  • Altshuler Shaham left its Corcept Therapeutics share count unchanged in Q2 2026.
  • Corcept Therapeutics made up ﹤0.01% of Altshuler Shaham's portfolio in Q2 2026, its #331 holding.
  • Altshuler Shaham first reported a position in Corcept Therapeutics in Q2 2020 and has held it in 12 quarters since.
  • Altshuler Shaham's Corcept Therapeutics position peaked at $58K in Q3 2022.
  • 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Altshuler Shaham's 13F filing for Q2 2026, filed 12 Aug 2026.